Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Vasomotor Symptoms
.
Show all posts
Showing posts with label
Vasomotor Symptoms
.
Show all posts
Saturday, February 3, 2024
FDA Approves Veozah (fezolinetant) for the Treatment of Vasomotor Symptoms Due to Menopause
›
Astellas Pharma Inc. announced the U.S. Food and Drug Administration (FDA) approval of Veozah (fezolinetant) 45 mg once daily for the tr...
›
Home
View web version